Literature DB >> 32814270

Validity of a clinical scale in predicting the failure of non-invasive ventilation in hypoxemic patients.

Andrés Carrillo1, Antonia Lopez1, Luna Carrillo1, Vania Caldeira2, Miguel Guia3, Nuria Alonso1, Ana Renedo1, Maria E Quintana1, Juan M Sanchez1, Antonio Esquinas1.   

Abstract

INTRODUCTION: The HACOR scale is a clinical score that can predict early failure of NIV in hypoxemic acute respiratory failure (ARF) The aim of this study is to analyze the validity of the HACOR scale.
METHODS: A retrospective study of a cohort of over 2749 episodes on 2711 consecutive patients requiring NIV for hypoxemic ARF in a polyvalent intensive care unit. The scale was measured before starting NIV and at 1, 6, 12, 24 and 48 h after the initiation of NIV.
RESULTS: NIV failure occurred in 963 patients (35%). The value of the HACOR scale before NIV did not differ between success and failure. However, at 1, 6, 12, 24 and 48 h of NIV, the scale values clearly differed between the two groups. The HACOR scale at NIV initiation accurately predicts NIV failure in the first hour, with an optimal cut-off value of 8 points. The AUC for predicting NIV failure with HACOR at 1 h is greater than 0.9 in patients with pneumonia and adult respiratory distress syndrome (ARDS).
CONCLUSIONS: The HACOR scale measured at 1 h after NIV initiation accurately predicts NIV failure, especially in pneumonia and ARDS.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hypoxemic acute respiratory failure HACOR scale; Non-invasive ventilation

Mesh:

Year:  2020        PMID: 32814270     DOI: 10.1016/j.jcrc.2020.08.008

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  7 in total

1.  The HACOR Score Predicts Worse in-Hospital Prognosis in Patients Hospitalized with COVID-19.

Authors:  Massimo Raffaele Mannarino; Vanessa Bianconi; Elena Cosentini; Filippo Figorilli; Costanza Natali; Giulia Cellini; Cecilia Colangelo; Francesco Giglioni; Marco Braca; Matteo Pirro
Journal:  J Clin Med       Date:  2022-06-18       Impact factor: 4.964

2.  Comparison of ROX and HACOR scales to predict high-flow nasal cannula failure in patients with SARS-CoV-2 pneumonia.

Authors:  Carlos Fernando Valencia; Oscar David Lucero; Onofre Casas Castro; Andrey Alexandrovich Sanko; Peter Alfonso Olejua
Journal:  Sci Rep       Date:  2021-11-19       Impact factor: 4.379

3.  Intubation to Nowhere in COVID-19: Can Noninvasive Ventilation Help?

Authors:  Philippe R Bauer
Journal:  Mayo Clin Proc       Date:  2021-11-12       Impact factor: 11.104

4.  Early assessment of the efficacy of noninvasive ventilation tested by HACOR score to avoid delayed intubation in patients with moderate to severe ARDS.

Authors:  Linfu Bai; Fei Ding; Weiming Xiong; Weiwei Shu; Lei Jiang; Yuliang Liu; Jun Duan
Journal:  Ther Adv Respir Dis       Date:  2022 Jan-Dec       Impact factor: 4.031

5.  Use of CPAP Failure Score to Predict the Risk of Helmet-CPAP Support Failure in COVID-19 Patients: A Retrospective Study.

Authors:  Francesco Alessandri; Antonella Tosi; Francesco De Lazzaro; Chiara Andreoli; Andrea Cicchinelli; Cosima Carrieri; Quirino Lai; Francesco Pugliese
Journal:  J Clin Med       Date:  2022-05-05       Impact factor: 4.241

Review 6.  Noninvasive respiratory support and patient self-inflicted lung injury in COVID-19: a narrative review.

Authors:  Denise Battaglini; Chiara Robba; Lorenzo Ball; Pedro L Silva; Fernanda F Cruz; Paolo Pelosi; Patricia R M Rocco
Journal:  Br J Anaesth       Date:  2021-06-03       Impact factor: 11.719

7.  Usefulness of the HACOR score in predicting success of CPAP in COVID-19-related hypoxemia.

Authors:  Miguel Filipe Guia; José Pedro Boléo-Tomé; Pasquale Imitazione; Giorgio Emanuele Polistina; Carlos Alves; Oki Ishikawa; Matthew Ballenberger; Bushra Mina; Giuseppe Fiorentino; Antonio Esquinas; Raffaele Scala
Journal:  Respir Med       Date:  2021-07-27       Impact factor: 4.582

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.